USE OF FOLK MEDICINE AND MODERN METHODS IN THE TREATMENT OF BRAIN CANCER
Article Sidebar
Main Article Content
Abstract
In this study, the effect of the Majmuiy Raxmoniy and Askaltsiy complex on the immune response via apoptosis and the interleukin system in brain tumors was investigated. The results demonstrated that the preparation possesses antioxidant, immunoregulatory, and apoptogenic properties.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Louis, D. N., Perry, A., Reifenberger, G. et al. (2021). The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica, 142(3), 341–358.
2.Fulda, S., & Debatin, K. M. (2019). Apoptosis pathways in neuroblastoma therapy. Cancer Letters, 469, 77–84.
3.Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer, 26(4), 239–257.
4.Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674.
5.Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicologic Pathology, 35(4), 495–516.
6.Poon, I. K. H., Lucas, C. D., Rossi, A. G., & Ravichandran, K. S. (2014). Apoptotic cell clearance: basic biology and therapeutic potential. Nature Reviews Immunology, 14(3), 166–180.
7.Martinez, F. O., & Gordon, S. (2014). The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Reports, 6, 13.
8.Lotfi, R., Herzog, G. I., & Baumann, I. (2020). Danger signals in glioblastoma: DAMPs and extracellular ATP promote immunosuppression and tumor progression. Frontiers in Immunology, 11, 595034.
9.Farkona, S., Diamandis, E. P., & Blasutig, I. M. (2016). Cancer immunotherapy: The beginning of the end of cancer? BMC Medicine, 14(1), 73.
10.Xu, D., Lin, T. H., & Li, S. (2022). Natural flavonoids as apoptosis inducers in glioblastoma cells: molecular mechanisms and therapeutic potential. Frontiers in Pharmacology, 13, 875421.
11.Kumar, S., Pandey, A. K. (2013). Chemistry and biological activities of flavonoids: An overview. The Scientific World Journal, 2013, 162750.
12.Su, J., & Ye, Y. (2021). Natural compounds in glioblastoma therapy: Modulation of apoptosis and immune response. Phytomedicine, 91, 153692.
13.Zhao, H., Jiang, J., Fan, X., & Hu, W. (2020). Interleukin-mediated immune regulation in glioblastoma: From mechanisms to therapies. Frontiers in Immunology, 11, 594659.
14.Liu, Y., Zeng, B., Zhang, Z. et al. (2021). Targeting NF-κB and STAT3 signaling pathways in glioblastoma: role of phytochemicals. Frontiers in Oncology, 11, 642349.
15.Al-Snafi, A. E. (2020). Therapeutic properties of natural plant-derived bioactive compounds with anti-glioma effects. Journal of Pharmaceutical Research International, 32(9), 39–55.